Logo image of ALKLH.PA

KLEA HOLDING (ALKLH.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALKLH - FR0013481835 - Common Stock

0.2225 EUR
+0 (+1.37%)
Last: 1/6/2026, 7:00:00 PM
Fundamental Rating

4

Overall ALKLH gets a fundamental rating of 4 out of 10. We evaluated ALKLH against 65 industry peers in the Health Care Equipment & Supplies industry. ALKLH has only an average score on both its financial health and profitability. ALKLH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ALKLH has reported negative net income.
ALKLH had a positive operating cash flow in the past year.
In multiple years ALKLH reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALKLH reported negative operating cash flow in multiple years.
ALKLH.PA Yearly Net Income VS EBIT VS OCF VS FCFALKLH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of 6.70%, ALKLH is in the better half of the industry, outperforming 72.31% of the companies in the same industry.
ALKLH has a Return On Equity (8.86%) which is in line with its industry peers.
ALKLH's Return On Invested Capital of 7.72% is fine compared to the rest of the industry. ALKLH outperforms 64.62% of its industry peers.
Industry RankSector Rank
ROA 6.7%
ROE 8.86%
ROIC 7.72%
ROA(3y)-2.83%
ROA(5y)-21.15%
ROE(3y)-4.32%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALKLH.PA Yearly ROA, ROE, ROICALKLH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

1.3 Margins

The Profit Margin of ALKLH (11.89%) is better than 70.77% of its industry peers.
With a decent Operating Margin value of 13.95%, ALKLH is doing good in the industry, outperforming 64.62% of the companies in the same industry.
ALKLH's Gross Margin of 94.17% is amongst the best of the industry. ALKLH outperforms 98.46% of its industry peers.
In the last couple of years the Gross Margin of ALKLH has grown nicely.
Industry RankSector Rank
OM 13.95%
PM (TTM) 11.89%
GM 94.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.3%
GM growth 5Y22.31%
ALKLH.PA Yearly Profit, Operating, Gross MarginsALKLH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALKLH is destroying value.
ALKLH has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALKLH has been increased compared to 5 years ago.
ALKLH has a better debt/assets ratio than last year.
ALKLH.PA Yearly Shares OutstandingALKLH.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ALKLH.PA Yearly Total Debt VS Total AssetsALKLH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 4.91 indicates that ALKLH is not in any danger for bankruptcy at the moment.
The Altman-Z score of ALKLH (4.91) is better than 83.08% of its industry peers.
The Debt to FCF ratio of ALKLH is 7.06, which is on the high side as it means it would take ALKLH, 7.06 years of fcf income to pay off all of its debts.
ALKLH has a Debt to FCF ratio (7.06) which is in line with its industry peers.
A Debt/Equity ratio of 0.09 indicates that ALKLH is not too dependend on debt financing.
ALKLH has a better Debt to Equity ratio (0.09) than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 7.06
Altman-Z 4.91
ROIC/WACC1
WACC7.72%
ALKLH.PA Yearly LT Debt VS Equity VS FCFALKLH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

ALKLH has a Current Ratio of 1.26. This is a normal value and indicates that ALKLH is financially healthy and should not expect problems in meeting its short term obligations.
ALKLH has a Current ratio of 1.26. This is in the lower half of the industry: ALKLH underperforms 64.62% of its industry peers.
A Quick Ratio of 1.25 indicates that ALKLH should not have too much problems paying its short term obligations.
ALKLH has a better Quick ratio (1.25) than 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.25
ALKLH.PA Yearly Current Assets VS Current LiabilitesALKLH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

5

3. Growth

3.1 Past

ALKLH shows a strong growth in Revenue. In the last year, the Revenue has grown by 37.41%.
ALKLH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.01% yearly.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)37.41%
Revenue growth 3Y34%
Revenue growth 5Y11.01%
Sales Q2Q%45.84%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 24.27% on average over the next years. This is a very strong growth
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year34.18%
Revenue Next 2Y24.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALKLH.PA Yearly Revenue VS EstimatesALKLH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M 25M
ALKLH.PA Yearly EPS VS EstimatesALKLH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2025 2026 0 -2 -4 -6 -8 -10

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Forward Earnings ratio of 10.80 indicates a reasonable valuation of ALKLH.
ALKLH's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALKLH is cheaper than 89.23% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.79. ALKLH is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 10.8
ALKLH.PA Price Earnings VS Forward Price EarningsALKLH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALKLH is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALKLH indicates a slightly more expensive valuation: ALKLH is more expensive than 61.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 97.74
EV/EBITDA 21.76
ALKLH.PA Per share dataALKLH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.02 0.04 0.06 0.08

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALKLH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

KLEA HOLDING

EPA:ALKLH (1/6/2026, 7:00:00 PM)

0.2225

+0 (+1.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-21 2025-07-21
Earnings (Next)N/A N/A
Inst Owners1.26%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap68.42M
Revenue(TTM)20.86M
Net Income(TTM)2.48M
Analysts86.67
Price Target0.51 (129.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.8
P/S 3.28
P/FCF 97.74
P/OCF 52.23
P/B 2.46
P/tB 27.48
EV/EBITDA 21.76
EPS(TTM)0
EYN/A
EPS(NY)0.02
Fwd EY9.26%
FCF(TTM)0
FCFY1.02%
OCF(TTM)0
OCFY1.91%
SpS0.07
BVpS0.09
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 6.7%
ROE 8.86%
ROCE 9.41%
ROIC 7.72%
ROICexc 8.64%
ROICexgc 105.58%
OM 13.95%
PM (TTM) 11.89%
GM 94.17%
FCFM 3.36%
ROA(3y)-2.83%
ROA(5y)-21.15%
ROE(3y)-4.32%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.3%
GM growth 5Y22.31%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 7.06
Debt/EBITDA 0.76
Cap/Depr 196.77%
Cap/Sales 2.92%
Interest Coverage 250
Cash Conversion 40.68%
Profit Quality 28.23%
Current Ratio 1.26
Quick Ratio 1.25
Altman-Z 4.91
F-Score5
WACC7.72%
ROIC/WACC1
Cap/Depr(3y)159.06%
Cap/Depr(5y)N/A
Cap/Sales(3y)20.56%
Cap/Sales(5y)13.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)37.41%
Revenue growth 3Y34%
Revenue growth 5Y11.01%
Sales Q2Q%45.84%
Revenue Next Year34.18%
Revenue Next 2Y24.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y206.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year310%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y108.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y145.85%
OCF growth 3YN/A
OCF growth 5YN/A

KLEA HOLDING / ALKLH.PA FAQ

What is the fundamental rating for ALKLH stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALKLH.PA.


Can you provide the valuation status for KLEA HOLDING?

ChartMill assigns a valuation rating of 2 / 10 to KLEA HOLDING (ALKLH.PA). This can be considered as Overvalued.


What is the profitability of ALKLH stock?

KLEA HOLDING (ALKLH.PA) has a profitability rating of 4 / 10.